Herpes drug inhibits HIV replication, but with a price

Nov 06, 2008

The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC. This beneficial effect does pose a risk though, as HIV-infected cells treated with acyclovir promote the emergence of multi-drug resistant HIV variants.

HIV and herpes (HSV) are two of the most common sexually transmitted diseases worldwide, and individuals frequently become co-infected with both. In such cases, the two viruses interact with each other; the presence of HIV often results in more frequent HSV lesion outbreaks, while HSV can speed up the progression of HIV to AIDS.

Considering their interaction, recent studies showing that acyclovir treatment could reduce HIV viral load in co-infected patients were not surprising, and attributed to an indirect effect of HSV suppression. However, Moira McMahon and colleagues at Johns Hopkins decided to look whether the effects on HIV might be direct.

They used a sensitive infection assay of white blood cells and found that acyclovir can directly inhibit HIV replication. The drug specifically targeted RT, the key HIV enzyme that converts the virus' RNA into DNA so it can be replicated. However, acyclovir treatment had some unexpected results; as early as five days after initial infection, a mutant version of HIV (V75I) appeared in the cells, and within 94 days spread to comprise over 90% of the viral population. The V75I strain is part of the resistance pathway to many drugs, including the commonly used RT inhibitors.

What this means, the authors note, is that acyclovir could be a great model for designing future HIV treatments, but also could be a risky drug if given to HSV patients co-infected with HIV by potentially promoting cross-resistance to current treatments.

Source: American Society for Biochemistry and Molecular Biology

Explore further: Slimy fish and the origins of brain development

add to favorites email to friend print save as pdf

Related Stories

Herpes medication does not reduce risk of HIV transmission

Jan 20, 2010

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause ...

Herpes medication does not reduce risk of HIV transmission

May 08, 2009

A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital ...

Recommended for you

Slimy fish and the origins of brain development

7 minutes ago

Lamprey—slimy, eel-like parasitic fish with tooth-riddled, jawless sucking mouths—are rather disgusting to look at, but thanks to their important position on the vertebrate family tree, they can offer ...

Global importance of pollinators underestimated

10 minutes ago

(Phys.org) —Declines in populations of pollinators, such as bees and wasps, may be a key threat to nutrition in some of the most poorly fed parts of the globe, according to new research.

New concepts based on advances in animal systematics

18 minutes ago

The way in which most multicellular organisms have been classified has been the same for more than a century. Only recently have scientists developed the tools and knowledge to question the way we classify ...

User comments : 0